Literature DB >> 27576207

Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.

Michael P Whyte1, Deborah Wenkert2, Fan Zhang2.   

Abstract

Hypophosphatasia (HPP) is the inborn-error-of-metabolism that features deficient activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). Resultant extracellular accumulation of inorganic pyrophosphate, a TNSALP substrate and potent inhibitor of mineralization, typically leads to tooth loss and sometimes to rickets or osteomalacia. HPP's remarkably broad-ranging severity is largely explained by autosomal dominant versus autosomal recessive transmission from among several hundred usually missense mutations positioned throughout the gene that encodes TNSALP. In 2015, our cross-sectional investigation of 173 affected children validated and expanded the clinical nosology commonly used for pediatric HPP. Herein, for the 101 patients in that cohort with longitudinal data, we explored the natural history of pediatric HPP by assessing their z-scores for height and then for weight, grip strength, and bone mineral density (BMD) determined by dual energy X-ray absorptiometry (DXA) also after adjusting for patient height. Eighteen patients contributed to "across" puberty evaluation. According to increasing HPP severity, there were 28 odonto HPP, 28 mild childhood HPP, 37 severe childhood HPP, and 8 infantile HPP patients typically studied from early to mid-childhood. The individual values for each parameter were wide-ranging within, and overlapping between, the four successive patient groups. Final mean/median z-scores, like the published initial values, paralleled the nosology. Longitudinal findings were similar for the boys versus girls and across puberty. Mean/median height z-scores remained constant for all four patient groups. In contrast, mean/median weight z-scores increased with aging, including after height-adjustment, resembling the recent trend for American children. However, excessive weight gain was typically not observed and mean/median values became average for height. Mean/median z-scores calculated routinely for chronologic age did not change for grip strength or for lumbar spine or total hip BMD. However, height-correction of the cohort suggested some worsening of grip strength z-scores and indicated improvement in spine BMD z-scores. Overall, in affected children and adolescents, HPP represents a clinically stable but chronic disorder.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Dual energy X-ray absorptiometry; Inborn-error-of-metabolism; Metabolic bone disease; Orphan disease; Rickets

Mesh:

Year:  2016        PMID: 27576207     DOI: 10.1016/j.bone.2016.08.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  26 in total

Review 1.  Cellular and extracellular matrix of bone, with principles of synthesis and dependency of mineral deposition on cell membrane transport.

Authors:  Paul H Schlesinger; Harry C Blair; Donna Beer Stolz; Vladimir Riazanski; Evan C Ray; Irina L Tourkova; Deborah J Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

2.  Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.

Authors:  S A Bowden; B H Adler
Journal:  Osteoporos Int       Date:  2017-10-18       Impact factor: 4.507

3.  X-linked myotubular myopathy: A prospective international natural history study.

Authors:  Mélanie Annoussamy; Charlotte Lilien; Teresa Gidaro; Elena Gargaun; Virginie Chê; Ulrike Schara; Andrea Gangfuß; Adele D'Amico; James J Dowling; Basil T Darras; Aurore Daron; Arturo Hernandez; Capucine de Lattre; Jean-Michel Arnal; Michèle Mayer; Jean-Marie Cuisset; Carole Vuillerot; Stéphanie Fontaine; Rémi Bellance; Valérie Biancalana; Ana Buj-Bello; Jean-Yves Hogrel; Hal Landy; Laurent Servais
Journal:  Neurology       Date:  2019-03-22       Impact factor: 9.910

Review 4.  Dental manifestation and management of hypophosphatasia.

Authors:  Rena Okawa; Kazuhiko Nakano
Journal:  Jpn Dent Sci Rev       Date:  2022-07-02

5.  Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators.

Authors:  E Y Chu; T D Vo; M B Chavez; A Nagasaki; E L Mertz; F H Nociti; S F Aitken; D Kavanagh; K Zimmerman; X Li; P R Stabach; D T Braddock; J L Millán; B L Foster; M J Somerman
Journal:  Bone       Date:  2020-03-26       Impact factor: 4.398

6.  Tissue nonspecific alkaline phosphatase promotes calvarial progenitor cell cycle progression and cytokinesis via Erk1,2.

Authors:  Hwa Kyung Nam; Iva Vesela; Erica Siismets; Nan E Hatch
Journal:  Bone       Date:  2018-10-17       Impact factor: 4.398

7.  Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia.

Authors:  Raquel Sanabria-de la Torre; Luis Martínez-Heredia; Sheila González-Salvatierra; Francisco Andújar-Vera; Iván Iglesias-Baena; Juan Miguel Villa-Suárez; Victoria Contreras-Bolívar; Mario Corbacho-Soto; Gonzalo Martínez-Navajas; Pedro J Real; Cristina García-Fontana; Manuel Muñoz-Torres; Beatriz García-Fontana
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

8.  Clinical and Genetic Findings of Turkish Hypophosphatasia Cases.

Authors:  Halil Sağlam; Şahin Erdöl; Sevil Dorum
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-06-30

9.  Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia.

Authors:  Rena Okawa; Kazuma Kokomoto; Kazuhiko Nakano
Journal:  BMC Oral Health       Date:  2021-06-27       Impact factor: 2.757

10.  Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.

Authors:  Michael P Whyte; Fan Zhang; Deborah Wenkert; Steven Mumm; Theresa J Berndt; Rajiv Kumar
Journal:  Bone       Date:  2020-02-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.